Fingerprint
Dive into the research topics of 'Phase 1 study of the PI3Kd inhibitor INCB040093 6 JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1 study of the PI3Kd inhibitor INCB040093 6 JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma
Tycel J. Phillips, Andres Forero-Torres, Taimur Sher, Catherine S. Diefenbach, Patrick Johnston, Moshe Talpaz, Jennifer Pulini, Li Zhou, Peggy Scherle, Xuejun Chen, Paul M. Barr
Research output: Contribution to journal › Article › peer-review
24
Scopus
citations